dd hello thx for your posts. If I may ask 1. How is it “known” that FDA has seen interim data? 2. How is it known that FDA would have stopped compassionate use?
Those seem rather compelling arguments from which one may infer the likelihood of post TLD approval. But they also seem obvious, and do not rely on new facts, yet I do not recall having seen this point having been made previously. (Could have missed it of course). TIA GLTA
Market Data 
Markets 
AI
